Pharmacy-based molecular point-of-care testing for hepatitis C (HCV) in high-risk patients: feasibility and linkage to care

被引:0
|
作者
Rogers, Benedict [1 ,2 ]
Spear, James [3 ]
Mistry, Vinay [4 ]
Wiselka, Martin [1 ,2 ]
Pareek, Manish [1 ,2 ]
机构
[1] Univ Hosp Leicester NHS Trust, Infect Dis & HIV Med, Leicester, Leics, England
[2] Univ Leicester, Resp Sci, Leicester, Leics, England
[3] Univ Hosp Leicester, Hepatitis C Operat Delivery Network, Leicester, Leics, England
[4] Leicestershire Local Pharmaceut Comm, Leicester, Leics, England
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
THU342
引用
收藏
页码:S307 / S307
页数:1
相关论文
共 50 条
  • [21] Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study)
    Calvaruso, Vincenza
    Bronte, Fabrizio
    Ferraro, Donatella
    Reina, Giada
    Conte, Elisabetta
    Rini, Francesca
    Magro, Bianca
    Petta, Salvatore
    Di Marco, Vito
    Craxi, Antonio
    LIVER INTERNATIONAL, 2019, 39 (12) : 2240 - 2243
  • [22] Molecular Point-of-Care Testing for Hepatitis C: Available Technologies, Pipeline, and Promising Future Directions
    Reipold, Elena Ivanova
    Shilton, Sonjelle
    Donolato, Marco
    Suarez, Marta Fernandez
    JOURNAL OF INFECTIOUS DISEASES, 2024, 229 : S342 - S349
  • [23] Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department
    Hutton, J.
    Doyle, J.
    Zordan, R.
    Weiland, T.
    Cocco, A.
    Howell, J.
    Iser, S.
    Snell, J.
    Fry, S.
    New, K.
    Sloane, R.
    Jarman, M.
    Phan, D.
    Tran, S.
    Pedrana, A.
    Williams, B.
    Johnson, J.
    Glasgow, S.
    Thompson, A.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 72 : 84 - 90
  • [24] Evaluation of pharmacy-based HIV testing in a high-risk New York City community
    S Amesty
    N Crawford
    V Nandi
    A Rivera
    C Fuller
    BMC Infectious Diseases, 14 (Suppl 2)
  • [25] Evaluation of Pharmacy-Based HIV Testing in a High-Risk New York City Community
    Amesty, Silvia
    Crawford, Natalie D.
    Nandi, Vijay
    Perez-Figueroa, Rafael
    Rivera, Alexis
    Sutton, Madeline
    Weidle, Paul J.
    Willis, Leigh
    Smith, Dawn K.
    Hernandez, Carolyn
    Harripersaud, Katherine
    Lewis, Crystal Fuller
    AIDS PATIENT CARE AND STDS, 2015, 29 (08) : 437 - 444
  • [26] Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis and Linkage to Care in High-Risk Populations
    Ford, Mary M.
    Jordan, Ashly E.
    Johnson, Nirah
    Rude, Eric
    Laraque, Fabienne
    Varma, Jay K.
    Hagan, Holly
    JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2018, 24 (01): : 41 - 48
  • [27] Molecular point-of-care testing in the community pharmacy setting: current status and future prospects
    Klepser, Michael
    Koski, Renee R.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2022, 22 (10) : 923 - 936
  • [28] Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy
    Brewer, Alexander
    Hanna, Cathy
    Eckmann, Lynne
    Schadler, Aric
    Divine, Holly
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2018, 58 (04) : S69 - +
  • [29] Cost-effectiveness analysis of hepatitis C virus (HCV) point-of-care assay for HCV screening
    Koo, Vanessa
    Tian, Feng
    Wong, William W. L.
    LIVER INTERNATIONAL, 2022, 42 (04) : 787 - 795
  • [30] Pharmacy-Based Infectious Disease Management Programs Incorporating CLIA-Waived Point-of-Care Tests
    Herbin, S. R.
    Klepser, D. G.
    Klepser, M. E.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (05)